Serial #97353480
LIVE

Serial Number

97353480

Owner

CSL Behring L.L.C.

Attorney

Scott D. Woldow

Filing Date

Apr 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97353480 Trademark

Serial Number: 97353480

Serial #97353480 is a trademark filed by CSL Behring L.L.C. on April 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CSL Behring L.L.C.

1020 First Avenue
King of Prussia, PA 13502

Entity Type: 16

Trademark Details

Filing Date

April 8, 2022

Registration Date

Not Registered

Published for Opposition

April 4, 2023

Goods & Services

Medical information services; Providing healthcare information; Healthcare information services, namely, advice and consultation with patients and caregivers regarding the use and administration of pharmaceutical and healthcare products; Medical information services in the field of blood diseases, illnesses and conditions, transplant conditions, renal conditions, kidney conditions and antibody mediated rejection conditions; Medical services, namely, providing medical information concerning blood products, providing medical information concerning pharmaceutical products, including providing information on preparing and self-administering medications; health care, namely, providing health care information by telephone, the internet, and through the distribution of printed matter; charitable services, namely, providing medical information to patients and caregivers for obtaining medications and medical treatment; Providing medical information for patients diagnosed with medical conditions regarding available resources and treatments and steps and actions for wellness, physical fitness and healthy living; providing medical counseling, mentoring and guidance for patients with medical conditions; providing charitable services, namely, providing pharmaceutical consultation for the continuance of medication for those who are underinsured, uninsured, or who have experienced a lapse in insurance coverage; Providing medical information by text in the field of health to patients and health care providers; Providing medical information by email in the field of health to patients and health care providers; providing an Internet website portal featuring medical information for patients and healthcare providers

Promoting awareness of blood diseases, illnesses and conditions, transplant conditions, renal conditions, kidney conditions and antibody mediated rejection conditions; Promoting public awareness of blood diseases, illnesses and conditions, transplant conditions, renal conditions, kidney conditions and antibody mediated rejection conditions and its impact on patients, families, and care givers

Healthcare education services, namely, conducting educational programs for patients, caregivers and healthcare professionals concerning medical diseases, illnesses or conditions, its treatment and its impact on patients, patient families, caregivers and healthcare professionals; planning and conducting educational meetings in the nature of seminars and classes in the fields of medical diseases, illnesses or conditions, their treatment and their impact on patients, patient families, caregivers and healthcare professionals; Educational services, namely, providing educational speakers in the field of healthcare; Peer to peer healthcare provider coaching services in the field of healthcare; Medical training and teaching in the field of healthcare; Training services in the field of healthcare; Providing on-line training in the field of healthcare; Providing on-line training in the field of healthcare on a peer to peer basis; Training in the use of healthcare products and pharmaceuticals

Pharmaceutical preparations for the treatment of blood conditions; Pharmaceutical preparations for transplant conditions; Pharmaceutical preparations for renal transplant conditions; Pharmaceutical preparations for kidney diseases, illnesses and conditions; Pharmaceutical preparations for treatment of antibody mediated rejection in adult renal transplant recipients

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2026 EXRA
SOU EXTENSION 5 GRANTED
Apr 23, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 23, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Oct 30, 2025 EEXT
SOU EXTENSION 5 FILED
Oct 29, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2025 EXRA
SOU EXTENSION 4 GRANTED
Apr 30, 2025 EX4G
SOU EXTENSION 4 FILED
Apr 30, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 29, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 29, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 30, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 30, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 1, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 30, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 30, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 30, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 13, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2022 NWOS
NEW APPLICATION ENTERED
Apr 12, 2022 NWAP